However, as HTT regulates mTORC1, and mTORC1 is constitutively overactivated in mHTT-expressing cells [21], the response of MSNs to DRD2/DRD3 agonists in HD could differ from that under normal conditions. Here, DRD3 is linked to Huntington disease.